Features
Get A Demo
Plans
Sign Up
Login
All Federal Grant Programs
Molybdenum-99 Program
Posted
3/9/20
Assistance Listing Number
81.009
Overview
Grant Opportunities
1
Grant Awards
4
Federal Agency
Department of Energy
Applicant Types
Not listed
Beneficiary Types
Not listed
Additional Information
Not listed
Popular Federal Grant Opportunities
Not listed
Popular Federal Grant Awards
Not listed
Name
Description
Awardee
Assistance Type
Dollars Obligated
(Click to sort descending)
Award Date
(Click to sort descending)
Updated At
(Click to sort descending)
DENA0004011
NORTHSTAR INTENDS THROUGH THIS EFFORT TO COMPLETE SCALE-UP PRODUCTION OF MO-99 VIA THE NEUTRON CAPTURE PROCESS USING ENRICHED MOLYBDENUM-98 TARGET MATERIAL BY 1) OBTAINING APPROVAL OF A NEXT GENERATION TC-99M SEPARATION SYSTEM KNOWN INTERNALLY AS ORION. NORTHSTAR WILL CONTINUE USE OF ENRICHED MATERIAL THAT IS NOMINALLY ENRICHED TO AT LEAST 95% IN THE STABLE ISOTOPE MOLYBDENUM-98. THIS ENRICHMENT BOOST INCREASES THE IRRADIATION YIELD APPROXIMATELY FOUR (4) FOLD WITH THE SAME TARGET LOAD MASS. ADDITIONALLY, NORTHSTAR 2) WILL COMPLETE ESTABLISHMENT OF AUTOMATED TARGET DISSOLUTION AND FILLING SYSTEMS BY INSTALLING AN AUTOMATED CUSTOMER SHIPPING SYSTEM AT OUR BELOIT, WI FACILITY. A FURTHER PROJECT OBJECTIVE ALSO IS TO 3) COMPLETE SCALE-UP OF THE RECOVERY AND RECLAMATION PROCESS TO RECLAIM ENRICHED MOLYBDENUM-98 FROM SPENT GENERATOR AND PROCESSING MATERIAL ALLOWING FOR A SIGNIFICANTLY LOWER EFFECTIVE RAW MATERIAL COSTS OF TARGET MATERIAL. WE WILL 4) INSTALL QUALITY CONTROL EQUIPMENT AT OUR MURR FACILITY TO ACCELERATE MO-99 PRODUCT RELEASE TO CUSTOMERS AND ELIMINATE RELIANCE ON A THIRD PARTY LABORATORY. FURTHER, WE WILL 5) ACQUIRE ADDITIONAL ENRICHED MOLYBDENUM-98 TARGET MATERIAL TO MEET ALL TESTING AND SCALE-UP NEEDS.
Northstar Medical Technologies, LLC
Cooperative Agreement
$206.5m
9/2/21
10/4/24
DENA0004010
SHINE WAS FOUNDED IN 2010 WITH THE GOAL OF BECOMING THE WORLD LEADER IN THE SAFE, CLEAN, AFFORDABLE PRODUCTION OF MEDICAL ISOTOPES. SINCE 2010, SHINE HAS AGGRESSIVELY PURSUED THE ESTABLISHMENT OF A DOMESTIC SOURCE OF HIGH SPECIFIC ACTIVITY MO-99 WITHOUT THE USE OF HEU TO END THE CHRONIC SHORTAGES US PATIENTS ARE EXPERIENCING.
Shine Technologies, LLC
Cooperative Agreement
$459.1m
10/22/21
6/21/24
DENA0004013
NORTHSTAR INTENDS THROUGH THIS EFFORT TO COMPLETE SCALE-UP PRODUCTION OF MO-99 VIA THE ELECTRON ACCELERATOR IRRADIATION PROCESS USING ENRICHED MOLYBDENUM-100 TARGET MATERIAL BY 1) INITIATING AND BRINGING OPERATIONAL SECOND AND THIRD BUILDINGS DESIGNED TO HOUSE ELECTRON ACCELERATORS AT THE COMPANY'S BELOIT, WI SITE. ADDITIONALLY, NORTHSTAR WILL 2) INSTALL AND BRING OPERATIONAL TWO ADDITIONAL ELECTRON ACCELERATOR PAIRS TO BE USED FOR MO-99 PRODUCTION. A FURTHER PROJECT OBJECTIVE ALSO 3) INCORPORATE RECLAIMING ENRICHED MOLYBDENUM-100 TO THE RECOVERY AND RECLAMATION PROCESS FROM SPENT GENERATOR AND PROCESSING MATERIAL ALLOWING FOR SIGNIFICANTLY LOWER EFFECTIVE RAW MATERIAL COSTS OF TARGET MATERIAL. LASTLY, NORTHSTAR WILL 4) ACQUIRE ADDITIONAL MOLYBDENUM-100 TARGET MATERIAL TO ACCOMPLISH ALL TESTING AND SCALE- UP NEEDS.
Northstar Medical Technologies, LLC
Cooperative Agreement
$259.1m
9/2/21
11/27/23
DENA0004012
NIOWAVE IS CURRENTLY IN PHASE 2 OF A THREE-PHASE PROGRAM SUPPORTED BY THE NNSA MO-99 CA TO PRODUCE 10 KCI/WEEK (1,550 6-DAY CI/WEEK). UPON APPROVAL OF THIS SECOND CA, NIOWAVE WILL EXPEDITE ITS CURRENT PLANS TO COMMERCIAL-SCALE PRODUCTION AND DISTRIBUTION OF MO-99 BY DECEMBER 2023.
Niowave, Inc.
Cooperative Agreement
$3.3m
12/3/21
6/4/24
Name
Description
Solicitation Number
Federal Agency
Due Date
(Click to sort descending)
Posted Date
(Click to sort descending)
Commercial Domestic Production of Moly-99 without the Use of Highly Enriched Uranium
The U.S. Department of Energy National Nuclear Security Administration's (DOE/NNSA) Office of Material Management and Minimization (NA-23) is soliciting applications from commercial entities that will result in the award of one or more Cooperative Agreements to achieve commercial-scale production of the medical isotope, molybdenum-99, hereafter referred to as Mo-99, without the use of highly enriched uranium (HEU) in the United States. This FOA closes and applications are due September 30, 2020 by 11:59 p.m. EST. Please be aware that technical difficulties are always possible when submitting applications electronically, therefore, ensure enough time is allotted for submission to DOE/NNSA. DOE/NNSA will not consider any applications that are received after the application deadline. This includes applications which are received by DOE/NNSA late as a result of technical difficulties. Therefore, applicants are strongly encouraged to submit their applications well in advance of the application deadline. The applicant's proposal will be evaluated, in accordance with Section V of this FOA, to measure the degree to which the applicant's approach will enable their project to produce and sell at least 1,500 6-day Ci/week of Mo-99 without the use of HEU to the U.S. market on or before December 31, 2023.The applicant must also possess the ability and plans to increase the production of Mo-99 to 3,000 6-day Ci/week. This FOA is not intended to support Research and Development (R & D) projects, and the applicant must clearly demonstrate their ability to commercially produce Mo-99 on or before December 31, 2023. Awards under this FOA are subject to the availability of funds. Acceptance of an application for evaluation does not obligate DOE/NNSA to make an award. DOE/NNSA reserves the right to fund, in whole or in part, any, all, or none of the applications submitted in response to this FOA. DOE/NNSA also reserves the right to award with or without discussions with applicants. Cooperative Agreements (CA) will be awarded on a 50%/50% Federal/non-Federal cost-sharing basis whereby the U.S. Government can provide up to $35 million for one or more awards. The recipient will be required to match the U.S. Government contribution and must demonstrate funds are available by providing investor letters of commitment with each application. DOE/NNSA reserves the right to establish the maximum ceiling amount pre and post award. The funding will begin at or near the time of award and continue over the life of the stated project period of the CA, which will be for a period of three years from the date of award. Interested parties should carefully read the instructions for preparation of the application. If material or forms are omitted, the application is received after the closing date, or for any other reason an applicant does not provide a complete application by the closing date, the application will be rejected and will not be evaluated. DOE/NNSA does not intend to reissue this FOA. Therefore, any qualified candidates are encouraged to submit applications at this time. In the event that a Cooperative Agreement is terminated for any reason, following the award date, DOE/NNSA reserves the right to consider other qualified candidates from this FOA for evaluation and consideration. Cost Sharing: A 50%/50% cost-sharing arrangement between the U.S. Government and each recipient of federal funding in support of commercial projects, such as the Cooperative Agreements contemplated under this FOA, is required by the Energy Policy Act of 2005, Section 988, codified at 42 U.S.C. § 16352. This statute also prohibits DOE/NNSA from counting "proceeds from the prospective sale of an asset of an activity," such as the commercial sale of Mo-99 products, towards a recipient's required cost-sharing contribution. Therefore, applications that propose less than a 50 percent cost-share contribution from non-federal sponsors, or that propose the use of proceeds from the sale of assets generated under the activities of a Cooperative Agreement, shall not be considered for award. Repayment of the Federal share of the cost-shared activity shall not be required as a condition of the award. Investor Letters of Commitment will be required as part of the application.
DE-FOA-0002303
Department of Energy National Nuclear Security Administration
9/30/20
7/31/20